Trupanion, INC 8-K filings

Trupanion announced its second quarter 2026 financial results, showcasing an 11% increase in total revenue to $392.9 million, alongside the authorization of a significant $100 million share repurchase program.

Trupanion, Inc. announced the results of its 2026 Annual Meeting, including the election of nine directors, ratification of Ernst & Young LLP as auditor, and approval of executive compensation.

Trupanion, Inc. announced that board member Max Brodn will not stand for re-election at the upcoming 2026 Annual Meeting.

Trupanion, a leading pet medical insurance provider, announced robust financial results for the fourth quarter and full year ended December 31, 2025, achieving its 15% annual margin target.

Trupanion announced record quarterly profitability and accelerated subscription pet growth for Q3 2025, alongside securing a new $120 million credit facility with PNC Bank at a lower interest rate.

Trupanion, Inc. announced the appointment of Bradley S. Powell, former CFO of Expeditors International, to its Board of Directors, enhancing financial and strategic oversight.

Trupanion, Inc. reported a strong second quarter 2025, returning to net income and achieving robust growth in revenue, Adjusted EBITDA, and cash flow.

Trupanion, Inc. announced the results of its 2025 Annual Meeting, where stockholders re-elected all nine directors, ratified Ernst & Young LLP as auditor, approved executive compensation, and opted for annual 'Say on Pay' votes.

The New York Department of Financial Services has approved a $26 million extraordinary dividend to be paid to Trupanion, Inc. by its subsidiary, American Pet Insurance Company.

Trupanion's Q1 2025 financial results show revenue growth, improved profitability, and increased cash flow compared to the same period last year.

Trupanion announces positive Q4 and full year 2024 results, highlighting a 20% increase in subscription revenue and record free cash flow.

Trupanion announced a strong third quarter in 2024, marked by a 15% increase in total revenue and a 66% year-over-year increase in subscription discretionary profit.

Trupanion, Inc. has appointed John Gallagher as its new Chief Operating Officer, effective September 4, 2024.

Trupanion announced a strong second quarter with consistent revenue growth, margin expansion, and positive free cash flow.

Trupanion has appointed Margi Tooth as its new CEO, effective August 1, 2024, as part of a previously disclosed succession plan, and has granted her a significant compensation package.

Trupanion's 2024 Annual Meeting saw the election of eight directors, approval of a new equity incentive plan, and ratification of the company's auditor.

Trupanion reported a 19% increase in total revenue and a CEO transition, with Margi Tooth appointed as the new CEO effective August 1, 2024.

Two Trupanion board members, Daniel Levitan and Dr. Zay Satchu, will not seek re-election at the company's annual meeting in June 2024.

Trupanion's Q4 2023 results show accelerated subscription revenue growth and continued margin expansion, driving positive free cash flow.